Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters










Publication year range
1.
Oncol Rep ; 49(2)2023 Feb.
Article in English | MEDLINE | ID: mdl-36633146

ABSTRACT

Structural alterations of collagen impact signaling that helps control tumor progression and the responses to therapeutic intervention. Integrins represent a class of receptors that include members that mediate collagen signaling. However, a strategy of directly targeting integrins to control tumor growth has demonstrated limited activity in the clinical setting. New molecular understanding of integrins have revealed that these receptors can regulate both pro­ and anti­tumorigenic functions in a cell type­dependent manner. Therefore, designing strategies that block pro­tumorigenic signaling, without impeding anti­tumorigenic functions, may lead to development of more effective therapies. In the present study, evidence was provided for a novel signaling cascade in which ß3­integrin­mediated binding to a secreted RGDKGE­containing collagen fragment stimulates an autocrine­like signaling pathway that differentially governs the activity of both YAP and (protein kinase­A) PKA, ultimately leading to alterations in the levels of immune checkpoint molecule PD­L1 by a proteasome dependent mechanism. Selectively targeting this collagen fragment, reduced nuclear YAP levels, and enhanced PKA and proteasome activity, while also exhibiting significant antitumor activity in vivo. The present findings not only provided new mechanistic insight into a previously unknown autocrine­like signaling pathway that may provide tumor cells with the ability to regulate PD­L1, but our findings may also help in the development of more effective strategies to control pro­tumorigenic ß3­integrin signaling without disrupting its tumor suppressive functions in other cellular compartments.


Subject(s)
B7-H1 Antigen , Collagen , Integrins , Neoplasms , Peptide Fragments , Proteasome Endopeptidase Complex , Humans , B7-H1 Antigen/metabolism , Collagen/chemistry , Collagen/metabolism , Integrins/metabolism , Neoplasms/drug therapy , Neoplasms/metabolism , Proteasome Endopeptidase Complex/metabolism , Peptide Fragments/metabolism , YAP-Signaling Proteins/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism
2.
Front Psychol ; 12: 709023, 2021.
Article in English | MEDLINE | ID: mdl-34733201

ABSTRACT

The purpose of this study is to improve the English learning anxiety and learning effect for middle school students. From the perspective of educational psychology, the influence of vocalized reading practice on the English learning of students is studied based on the self-efficacy theory and the schema theory. To encourage the students to practice English, the study might solve the problem of insufficient opportunities by applying the artificial intelligence (AI) chat system to the oral English practice of the students. Several research hypotheses are put forward, which concern the correlation between the English learning anxiety of the students with their self-efficacy, topic familiarity, and English grades under vocalized reading practice. Then, the hypotheses are verified through a controlled trial and a questionnaire survey (QS). Afterward, the experimental and QS data are statistically analyzed and tested with a regression model. The results show that the English grades, self-efficacy, and topic familiarity of the students have been significantly improved in the experimental group after the vocalized reading practice. The significance coefficient of the regression model is P = 0.000 < 0.05, which can be used to verify the proposed hypotheses. The English grades, self-efficacy, and topic familiarity can well-predict the English learning anxiety of the students. The computer simulation in educational communication (CSIEC) teaching system and AI can help create an interactive learning environment for the students to practice oral English by chatting with AI robots.

3.
J Biomed Opt ; 26(6)2021 06.
Article in English | MEDLINE | ID: mdl-34159763

ABSTRACT

SIGNIFICANCE: Morphological collagen signatures are important for tissue function, particularly in the tumor microenvironment. A single algorithmic framework with quantitative, multiscale morphological collagen feature extraction may further the use of collagen signatures in understanding fundamental tumor progression. AIM: A modification of the 2D wavelet transform modulus maxima (WTMM) anisotropy method was applied to both digitally simulated collagen fibers and second-harmonic-generation imaged collagen fibers of mouse skin to calculate a multiscale anisotropy factor to detect collagen fiber organization. APPROACH: The modified 2D WTMM anisotropy method was initially validated on synthetic calibration images to establish the robustness and sensitivity of the multiscale fiber organization tool. Upon validation, the algorithm was applied to collagen fiber organization in normal wild-type skin, melanoma stimulated skin, and integrin α10KO skin. RESULTS: Normal wild-type skin collagen fibers have an increased anisotropy factor at all sizes scales. Interestingly, the multiscale anisotropy differences highlight important dissimilarities between collagen fiber organization in normal wild-type skin, melanoma stimulated, and integrin α10KO skin. At small scales (∼2 to 3 µm), the integrin α10KO skin was vastly different than normal skin (p-value ∼ 10 - 8), whereas the melanoma stimulated skin was vastly different than normal at large scales (∼30 to 40 µm, p-value ∼ 10 - 15). CONCLUSIONS: This objective computational collagen fiber organization algorithm is sensitive to collagen fiber organization across multiple scales for effective exploration of collagen morphological alterations associated with melanoma and the lack of α10 integrin binding.


Subject(s)
Second Harmonic Generation Microscopy , Animals , Anisotropy , Collagen , Diagnostic Imaging , Mice , Microscopy, Polarization
4.
Am J Pathol ; 191(3): 527-544, 2021 03.
Article in English | MEDLINE | ID: mdl-33307038

ABSTRACT

The growth and spread of malignant tumors, such as ovarian carcinomas, are governed in part by complex interconnected signaling cascades occurring between stromal and tumor cells. These reciprocal cross-talk signaling networks operating within the local tissue microenvironment may enhance malignant tumor progression. Understanding how novel bioactive molecules generated within the tumor microenvironment regulate signaling pathways in distinct cellular compartments is critical for the development of more effective treatment paradigms. Herein, we provide evidence that blocking cellular interactions with an RGDKGE-containing collagen peptide that selectively binds integrin ß3 on ovarian tumor cells enhances the phosphorylation of the hippo effector kinase large tumor suppressor kinase-1 and reduces nuclear accumulation of yes-associated protein and its target gene c-Myc. Selectively targeting this RGDKGE-containing collagen fragment inhibited ovarian tumor growth and the development of ascites fluid in vivo. These findings suggest that this bioactive collagen fragment may represent a previously unknown regulator of the hippo effector kinase large tumor suppressor kinase-1 and regulate ovarian tumor growth by a yes-associated protein-dependent mechanism. Taken together, these data not only provide new mechanistic insight into how a unique collagen fragment may regulate ovarian cancer, but in addition may help provide a useful new alternative strategy to control ovarian tumor progression based on selectively disrupting a previously unappreciated signaling cascade.


Subject(s)
Biomarkers, Tumor/metabolism , Collagen/metabolism , Ovarian Neoplasms/pathology , Peptide Fragments/metabolism , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins c-yes/metabolism , Animals , Apoptosis , Biomarkers, Tumor/genetics , Cell Proliferation , Female , Gene Expression Regulation, Neoplastic , Humans , Mice, Inbred C57BL , Mice, Nude , Phosphorylation , Protein Serine-Threonine Kinases/genetics , Proto-Oncogene Proteins c-yes/genetics , Signal Transduction , Tumor Cells, Cultured , Tumor Microenvironment , Xenograft Model Antitumor Assays
5.
J Cell Physiol ; 235(12): 9005-9020, 2020 12.
Article in English | MEDLINE | ID: mdl-32400053

ABSTRACT

Structural remodeling of the extracellular matrix is a well-established process associated with tumor growth and metastasis. Tumor and stromal cells that compose the tumor mass function cooperatively to promote the malignant phenotype in part by physically interacting with intact and structurally altered matrix proteins. To this end, collagen represents the most abundant component of the extracellular matrix and is known to control the behavior of histologically distinct tumor types as well as a diversity of stromal cells. Although a significant molecular understanding has been established concerning how cellular interactions with intact collagen govern signaling pathways that control tumor progression, considerably less is known concerning how interactions with cryptic or hidden regions within remodeled collagen may selectively alter signaling cascades, or whether inhibition of these cryptic signaling pathways may represent clinically effective therapeutic strategies. Here, we review the emerging evidence concerning the possible mechanisms for the selective generation of cryptic or hidden elements within collagen and their potential cell surface receptors that may facilitate signal transduction. We discuss the concept that cellular communication links between cell surface receptors and these cryptic collagen elements may serve as functional signaling hubs that coordinate multiple signaling pathways operating within both tumor and stromal cells. Finally, we provide examples to help illustrate the possibility that direct targeting of these unique cryptic signaling hubs may lead to the development of more effective therapeutic strategies to control tumor growth and metastasis.


Subject(s)
Collagen/metabolism , Neoplasm Metastasis/pathology , Neoplasms/metabolism , Neovascularization, Pathologic/pathology , Animals , Cell Movement/physiology , Cell Proliferation/physiology , Humans
6.
Int J Biochem Cell Biol ; 118: 105661, 2020 01.
Article in English | MEDLINE | ID: mdl-31805399

ABSTRACT

Ectonucleotide pyrophosphate phosphodiesterase type II (ENPP2), also known as Autotaxin (ATX), is an enzyme present in blood circulation that converts lysophosphatidyl choline (LPC) to lysophosphatidic acid (LPA). While LPA has been demonstrated to play diverse roles in skeletal myogenesis, mainly through in vitro studies, the role of ENPP2 in skeletal myogenesis has not been determined. We previously found that Enpp2 is induced by a positive WNT/ß-Catenin signaling regulator, R-spondin2 (RSPO2), in C2C12 myoblast cells. As RSPO2 promotes myogenic differentiation via the WNT/ß-Catenin signaling pathway, we hypothesized that ENPP2 may act as a key mediator for the crosstalk between WNT and LPA signaling during myogenic differentiation. Herein, we found that ENPP2 function is essential for myogenic differentiation in C2C12 cells. Pharmacological ENPP2 inhibitors or RNAi-mediated Enpp2 gene knockdown severely impaired the myogenic differentiation, including the cell fusion process, whereas administration of the recombinant ENPP2 protein enhanced myogenic differentiation. Consistent with the in vitro results, mice lacking the Enpp2 gene showed a disrupted muscle regeneration after acute muscle injury. The size of newly regenerated myofibers in Enpp2 mutant muscle was significantly reduced compared with wild-type regenerated muscle. Modified expression patterns of myogenic markers in Enpp2 mutant muscle further emphasized the impaired muscle regeneration process. Finally, we convincingly demonstrate that the Enpp2 gene is a direct transcriptional target for WNT/ß-Catenin signaling. Functional TCF/LEF1 binding sites within the upstream region of Enpp2 gene were identified by chromatin immunoprecipitation using anti-ß-Catenin antibodies and reporter assay. Our study reveals that ENPP2 is regulated by WNT/ß-Catenin signaling and plays a key positive role in myogenic differentiation.


Subject(s)
Cell Differentiation/genetics , Muscle Development/genetics , Phosphoric Diester Hydrolases/genetics , beta Catenin/genetics , Animals , Mice , Muscle, Skeletal/growth & development , Muscle, Skeletal/metabolism , Myoblasts/cytology , Regeneration/genetics , Wnt Proteins/genetics , Wnt Signaling Pathway/genetics
7.
Am J Pathol ; 188(10): 2356-2368, 2018 10.
Article in English | MEDLINE | ID: mdl-30118657

ABSTRACT

Stromal components not only help form the structure of neoplasms such as melanomas, but they also functionally contribute to their malignant phenotype. Thus, uncovering signaling pathways that integrate the behavior of both tumor and stromal cells may provide unique opportunities for the development of more effective strategies to control tumor progression. In this regard, extracellular matrix-mediated signaling plays a role in coordinating the behavior of both tumor and stromal cells. Here, evidence is provided that targeting a cryptic region of the extracellular matrix protein collagen (HU177 epitope) inhibits melanoma tumor growth and metastasis and reduces angiogenesis and the accumulation of α-SMA-expressing stromal cell in these tumors. The current study suggests that the ability of the HU177 epitope to control melanoma cell migration and metastasis depends on the transcriptional coactivator Yes-associated protein (YAP). Melanoma cell interactions with the HU177 epitope promoted nuclear accumulation of YAP by a cyclin-dependent kinase-5-associated mechanism. These findings provide new insights into the mechanism by which the anti-HU177 antibody inhibits metastasis, and uncovers an unknown signaling pathway by which the HU177 epitope selectively reprograms melanoma cells by regulating nuclear localization of YAP. This study helps to define a potential new therapeutic strategy to control melanoma tumor growth and metastasis that might be used alone or in combination with other therapeutics.


Subject(s)
Cell Movement/drug effects , Collagen/physiology , Epitopes/physiology , Melanoma/physiopathology , Skin Neoplasms/physiopathology , Adaptor Proteins, Signal Transducing/metabolism , Angiogenesis Inhibitors/pharmacology , Antibodies, Anti-Idiotypic/pharmacology , Antibodies, Anti-Idiotypic/physiology , Cell Proliferation/physiology , Collagen/immunology , Cyclin-Dependent Kinase 5/antagonists & inhibitors , Cyclin-Dependent Kinase 5/metabolism , Humans , Melanoma/pathology , Neoplasm Metastasis , Neovascularization, Pathologic/immunology , Phosphoproteins/metabolism , Phosphorylation/physiology , Skin Neoplasms/pathology , Stromal Cells/physiology , Talin/metabolism , Transcription Factors , Tumor Cells, Cultured , YAP-Signaling Proteins
8.
Oncotarget ; 8(5): 8900-8909, 2017 Jan 31.
Article in English | MEDLINE | ID: mdl-27823972

ABSTRACT

γδ T cells are one of the three immune cell types that express antigen receptors. They contribute to lymphoid antitumor surveillance and bridge the gap between innate and adaptive immunity. γδ T cells have the capacity of secreting abundant cytokines and exerting potent cytotoxicity against a wide range of cancer cells. γδ T cells exhibit important roles in immune-surveillance and immune defense against tumors and have become attractive effector cells for cancer immunotherapy. γδ T cells mediate anti-tumor therapy mainly by secreting pro-apoptotic molecules and inflammatory cytokines, or through a TCR-dependent pathway. Recently, γδ T cells are making their way into clinical trials. Some clinical trials demonstrated that γδ T cell-based immunotherapy is well tolerated and efficient. Despite the advantages that could be exploited, there are obstacles have to be addressed for the development of γδ T cell immunotherapies. Future direction for immunotherapy using γδ T cells should focus on overcoming the side effects of γδ T cells and exploring better antigens that help stimulating γδ T cell expansion in vitro.


Subject(s)
Immunotherapy, Adoptive/methods , Lymphocytes, Tumor-Infiltrating/immunology , Neoplasms/therapy , Receptors, Antigen, T-Cell, gamma-delta/immunology , T-Lymphocytes/transplantation , Animals , Cell Proliferation , Cytokines/immunology , Cytotoxicity, Immunologic , Humans , Lymphocyte Activation , Lymphocytes, Tumor-Infiltrating/metabolism , Lymphocytes, Tumor-Infiltrating/pathology , Neoplasms/immunology , Neoplasms/metabolism , Neoplasms/pathology , Phenotype , Receptors, Antigen, T-Cell, gamma-delta/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Tumor Escape
9.
PLoS One ; 8(6): e65344, 2013.
Article in English | MEDLINE | ID: mdl-23762348

ABSTRACT

The Snail gene family encodes zinc finger-containing transcriptional repressor proteins. Three members of the Snail gene family have been described in mammals, encoded by the Snai1, Snai2, and Snai3 genes. The function of the Snai1 and Snai2 genes have been studied extensively during both vertebrate embryogenesis and tumor progression and metastasis, and play critically important roles during these processes. However, little is known about the function of the Snai3 gene and protein. We describe here generation and analysis of Snai3 conditional and null mutant mice. We also generated an EYFP-tagged Snai3 null allele that accurately reflects endogenous Snai3 gene expression, with the highest levels of expression detected in thymus and skeletal muscle. Snai3 null mutant homozygous mice are viable and fertile, and exhibit no obvious phenotypic defects. These results demonstrate that Snai3 gene function is not essential for embryogenesis in mice.


Subject(s)
Embryonic Development/genetics , Founder Effect , Gene Expression Regulation, Developmental , Muscle, Skeletal/metabolism , Thymus Gland/metabolism , Transcription Factors/genetics , Animals , Embryo, Mammalian , Homozygote , Mice , Mice, Knockout , Muscle, Skeletal/embryology , Protein Isoforms/genetics , Protein Isoforms/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Signal Transduction , Snail Family Transcription Factors , Thymus Gland/embryology , Transcription Factors/metabolism
10.
Nanoscale Res Lett ; 5(6): 1039-44, 2010 Apr 16.
Article in English | MEDLINE | ID: mdl-20672131

ABSTRACT

Nearly monodisperse cobalt ferrite (CoFe2O4) nanoparticles without any size-selection process have been prepared through an alluring method in an oleylamine/ethanol/water system. Well-defined nanospheres with an average size of 5.5 nm have been synthesized using metal chloride as the law materials and oleic amine as the capping agent, through a general liquid-solid-solution (LSS) process. Magnetic measurement indicates that the particles exhibit a very high coercivity at 10 K and perform superparamagnetism at room temperature which is further illuminated by ZFC/FC curves. These superparamagnetic cobalt ferrite nanomaterials are considered to have potential application in the fields of biomedicine. The synthesis method is possible to be a general approach for the preparation of other pure binary and ternary compounds.

11.
Nanotechnology ; 21(9): 095708, 2010 Mar 05.
Article in English | MEDLINE | ID: mdl-20139492

ABSTRACT

Fe nanoflakes were prepared by the ball-milling technique, and then were coated with 20 nm-thick SiO(2) to prepare Fe/SiO(2) core-shell nanoflakes. Compared with the uncoated Fe nanoflakes, the permittivity of Fe/SiO(2) nanoflakes decreases dramatically, while the permeability decreases slightly. Consequently, reflection losses exceeding - 20 dB of Fe/SiO(2) nanoflakes are obtained in the frequency range of 3.8-7.3 GHz for absorber thicknesses of 2.2-3.6 mm, while the reflection loss of uncoated Fe nanoflakes almost cannot reach - 10 dB in the same thickness range. The enhanced microwave absorption of Fe/SiO(2) nanoflakes can be attributed to the combination of the proper electromagnetic impedance match due to the decrease of permittivity and large magnetic loss due to strong and broadband natural resonance. The key to the combination is the coexistence of the nanoshell microstructure and the nanoflake morphology.

12.
Vascul Pharmacol ; 50(5-6): 147-52, 2009.
Article in English | MEDLINE | ID: mdl-19073282

ABSTRACT

Beta-carboline alkaloids including harmalol, harmaline, norharmane, harmol, harmine and harmane are important constituents of the medicinal plant, Perganum harmala L. (Zygophylaceae), which has been used in traditional medicine. In the present study, the antiplatelet activities of six beta-carboline alkaloid compounds were investigated in vitro. At a concentration of 200 microM, these compounds have no effect on arachidonic acid (AA)-, thrombin- and U46619 (a thromboxane A2 mimic)-stimulated platelet aggregation. On the contrary, it was revealed that collagen-induced platelet aggregation could be inhibited by these compounds with different potencies (harmane and harmine were most potent, harmol had medium potency, and harmol, norharmane, harmalol and harmaline had a weak, non significant effect), indicating a selective inhibition on collagen-mediated platelet activation. Consistently, further study revealed that collagen-mediated phospholipase (PL) Cgamma2 and protein tyrosine phosphorylation, cytosolic calcium mobilization and arachidonic acid liberation were completely inhibited by harmane and harmine in a concentration-dependent manner, while the other compounds were only partially or not effective at all. Taken together, these results indicate that three of these six beta-carboline alkaloids can selectively affect collagen-induced platelet aggregation with different potencies; in particular, harmane and harmine were most potent, and their antiplatelet activities may be mediated by inhibiting PLCgamma2 and protein tyrosine phosphorylation with sequential suppression of cytosolic calcium mobilization and arachidonic acid liberation, indicating that harmane and harmine have a potential to be developed as a novel agent for atherothrombotic diseases.


Subject(s)
Alkaloids/pharmacology , Carbolines/pharmacology , Peganum , Phospholipase C gamma/metabolism , Platelet Aggregation/drug effects , Animals , Arachidonic Acid/metabolism , Blood Platelets/metabolism , Calcium/metabolism , Carbolines/chemistry , In Vitro Techniques , Male , Molecular Structure , Phosphorylation/drug effects , Phosphotyrosine/metabolism , Plant Extracts/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Rabbits , Structure-Activity Relationship
13.
J Asian Nat Prod Res ; 11(10): 867-75, 2009 Oct.
Article in English | MEDLINE | ID: mdl-20183248

ABSTRACT

The effects of catalponol (1) on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells were investigated. Catalponol at concentration ranges of 1-5 microM increased the intracellular levels of dopamine at 12-48 h. Catalponol at concentrations of up to 10 microM did not alter cell viability. Tyrosine hydroxylase (TH) activity was enhanced by 1 at 3 microM in a time-dependent manner, but aromatic L-amino acid decarboxylase activity was not. Catalponol also increased the intracellular levels of cyclic AMP and TH phosphorylation. In addition, catalponol at 3 microM associated with L-DOPA (20-50 microM) further enhanced the increases in dopamine levels induced by L-DOPA (50-100 microM) at 24 h. Catalponol at 2-5 microM inhibited L-DOPA (100-200 microM)-induced cytotoxicity at 48 h. These results suggest that 1 enhanced dopamine biosynthesis by inducing TH activity and protected against L-DOPA-induced cytotoxicity in PC12 cells, which was mediated by the increased levels of cyclic AMP.


Subject(s)
Dopamine/biosynthesis , Levodopa/pharmacology , Naphthols/pharmacology , Tyrosine 3-Monooxygenase/metabolism , Animals , Cell Survival/drug effects , Dose-Response Relationship, Drug , Naphthols/administration & dosage , PC12 Cells , Rats
14.
Biochem Pharmacol ; 75(6): 1331-40, 2008 Mar 15.
Article in English | MEDLINE | ID: mdl-18191105

ABSTRACT

The increased potential for growth of vascular smooth muscle cells (VSMCs) is a key abnormality in the development of atherosclerosis and postangioplasty restenosis. Platelet-derived growth factor (PDGF)-BB is a potent mitogen for VSMCs that plays an important role in the intimal accumulation of VSMCs. This study examined the effect of JM91, a newly synthesized indoledione derivative, on the proliferation of PDGF-BB-stimulated rat aortic VSMCs. The antiproliferative effect of JM91 on rat aortic VSMCs was examined by cell counting and [(3)H]thymidine incorporation assay. The pre-incubation of JM91 (0.5-3.0 microM) significantly inhibited the proliferation and DNA synthesis of 25 ng/mL PDGF-BB-stimulated rat aortic VSMCs in a concentration-dependent manner. JM91 inhibited the PDGF-BB-stimulated phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt kinase, while had no effect on PLCgamma1 and PDGF-Rbeta activation. In addition, treatment with JM91 (0.5-3.0 microM) induced cell-cycle arrest in the G(1) phase, which was associated with the down-regulation of cyclins and CDKs. These findings suggest that the inhibitory effects of JM91 against proliferation, DNA synthesis and cell cycle progression of PDGF-BB-stimulated rat aortic VSMCs are mediated by the suppression of the ERK1/2 and PI3K/Akt signaling pathways. Furthermore, JM91 may be a potential antiproliferative agent for the treatment of atherosclerosis and angioplasty restenosis.


Subject(s)
Cell Proliferation/drug effects , Myocytes, Smooth Muscle/drug effects , Protein Kinase Inhibitors/pharmacology , Quinolones/pharmacology , Quinones/pharmacology , Animals , Aorta/cytology , Becaplermin , Cell Cycle/drug effects , Cell Cycle Proteins/metabolism , Cells, Cultured , DNA/metabolism , Mitogen-Activated Protein Kinase 1/antagonists & inhibitors , Mitogen-Activated Protein Kinase 3/antagonists & inhibitors , Myocytes, Smooth Muscle/cytology , Myocytes, Smooth Muscle/metabolism , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation/drug effects , Platelet-Derived Growth Factor/pharmacology , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Proto-Oncogene Proteins c-sis , Rats , Retinoblastoma Protein/metabolism
15.
J Cardiovasc Pharmacol ; 51(1): 45-54, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18209568

ABSTRACT

We have previously reported that green tea catechins displayed a potent antithrombotic effect by inhibition of platelet aggregation. In the present study, the antiplatelet and antithrombotic activities of epigallocatechin gallate (EGCG), the major catechin derived from green tea, were extensively investigated. EGCG inhibited arterial thrombus formation and U46619-, collagen-, and arachidonic acid (AA)-induced washed rabbit platelet aggregation in a concentration-dependent manner, with IC50 values of 61 +/- 3, 85 +/- 4, and 99 +/- 4 microM, respectively. In line with the inhibition of collagen-induced platelet aggregation, EGCG revealed blocking of the collagen-mediated phospholipase (PL) Cgamma2 and protein tyrosine phosphorylation, and it caused concentration-dependent decreases of cytosolic calcium mobilization, AA liberation, and serotonin secretion. In addition, the platelet aggregation, intracellular Ca2+ mobilization, and protein tyrosine phosphorylation induced by thapsigargin, a Ca2(+)-ATPase pump inhibitor, were completely blocked by EGCG. Contrary to the inhibition of AA-induced platelet aggregation, EGCG failed to inhibit cyclooxygenase and thromboxane (TX) A2 synthase activities, but it concentration-dependently elevated AA-mediated PGD2 formation. In contrast, epigallocatechin (EGC), a structural analogue of EGCG lacking a galloyl group in the 3' position, slightly inhibited collagen-stimulated cytosolic calcium mobilization, but failed to affect other signal transductions as did EGCG in activated platelets and arterial thrombus formation. These results suggest that antiplatelet activity of EGCG may be attributable to its modulation of multiple cellular targets, such as inhibitions of PLCgamma2, protein tyrosine phosphorylation and AA liberation, and elevation of cellular PGD2 levels, as well as maintaining Ca2(+)-ATPase activity, which may underlie its beneficial effect on the atherothrombotic diseases.


Subject(s)
Catechin/analogs & derivatives , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation/drug effects , Tea/chemistry , Animals , Arachidonic Acid/metabolism , Calcium-Transporting ATPases/drug effects , Calcium-Transporting ATPases/metabolism , Catechin/administration & dosage , Catechin/pharmacology , Dose-Response Relationship, Drug , Inhibitory Concentration 50 , Male , Phospholipase C gamma/drug effects , Phospholipase C gamma/metabolism , Phosphorylation , Platelet Aggregation Inhibitors/administration & dosage , Prostaglandin D2/metabolism , Rabbits , Rats , Rats, Sprague-Dawley
16.
J Cell Biochem ; 104(1): 1-14, 2008 May 01.
Article in English | MEDLINE | ID: mdl-17979132

ABSTRACT

Diet can be one of the most important factors that influence risks for cardiovascular diseases. Hesperetin, a flavonoid present in grapefruits and oranges, is one candidate that may benefit the cardiovascular system. In this study, we have investigated the effect of hesperetin on the platelet-derived growth factor (PDGF)-BB-induced proliferation of primary cultured rat aortic vascular smooth muscle cells (VSMCs). Hesperetin significantly inhibited 50 ng/ml PDGF-BB-induced rat aortic VSMCs proliferation and [(3)H]-thymidine incorporation into DNA at concentrations of 5, 25, 50, and 100 microM. In accordance with these findings, hesperetin revealed blocking of the PDGF-BB-inducible progression through G(0)/G(1) to S phase of the cell cycle in synchronized cells. Western blot showed that hesperetin inhibited not only phosphorylation of retinoblastoma protein (pRb) and expressions of cyclin A, cyclin D, cyclin E, cyclin-dependent kinase 2 (CDK2) as well as proliferating cell nuclear antigen (PCNA) protein, but also downregulation of cyclin-dependent kinase inhibitor (CKI) p27(kip1), while did not affect CKI p21(cip1), p16(INK4), p53, and CDK4 expressions as well as early signaling transductions such as PDGF beta-receptor, extracellular signal-regulated kinase (ERK) 1/2, Akt, p38, and JNK phosphorylation. These results suggest that hesperetin inhibits PDGF-BB-induced rat aortic VSMCs proliferation via G(0)/G(1) arrest in association with modulation of the expression or activation of cell-cycle regulatory proteins, which may contribute to the beneficial effect of grapefruits and oranges on cardiovascular system.


Subject(s)
Aorta/cytology , Cell Cycle/drug effects , Cell Proliferation/drug effects , Hesperidin/pharmacology , Muscle, Smooth, Vascular/drug effects , Animals , Becaplermin , Cell Cycle Proteins/drug effects , Citrus/chemistry , Flavanones/pharmacology , Muscle, Smooth, Vascular/cytology , Platelet-Derived Growth Factor/pharmacology , Proto-Oncogene Proteins c-sis , Rats
17.
J Pharmacol Sci ; 105(2): 193-200, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17951980

ABSTRACT

NQ12, an antithrombotic agent, has been reported to display a potent antiplatelet activity. This study was undertaken to reveal the effect of NQ12 on rabbit platelet aggregation and signal transduction involved in the arachidonic acid (AA) cascade. NQ12 concentration-dependently suppressed collagen-, AA-, and U46619-induced rabbit platelet aggregation, with IC(50) values of 0.71 +/- 0.2, 0.82 +/- 0.3, and 0.45 +/- 0.1 microM, respectively. In addition, the concentration-response curve of U46619 was shifted to the right after NQ12 treatment, indicating an antagonism on thromboxane (TX) A(2) receptors. The collagen-stimulated AA liberation was inhibited by NQ12 in the same pattern as its inhibition of platelet aggregation. Further study revealed that NQ12 potently suppressed AA-mediated TXA(2) formation, but had no effect on the PGD(2) production, indicating an inhibitory effect on TXA(2) synthase, which was supported by a TXA(2) synthase activity assay indicating that NQ12 concentration-dependently inhibited TXA(2) formation converted from PGH(2). On the other hand, the AA-stimulated 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) formation was also suppressed by NQ12. Taken together, these results suggest that NQ12 has a potential to inhibit TXA(2) synthase activity and TXA(2) receptors, and it can modulate AA liberation as well as 12-HETE formation in platelets. This may be a convincing mechanism for the antithrombotic action of NQ12.


Subject(s)
Arachidonic Acid/metabolism , Fibrinolytic Agents/pharmacology , Naphthalenes/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation/drug effects , 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/biosynthesis , Animals , Dose-Response Relationship, Drug , Fibrinolytic Agents/administration & dosage , In Vitro Techniques , Inhibitory Concentration 50 , Naphthalenes/administration & dosage , Platelet Aggregation Inhibitors/administration & dosage , Prostaglandin D2/biosynthesis , Prostaglandin H2/metabolism , Rabbits , Receptors, Thromboxane A2, Prostaglandin H2/antagonists & inhibitors , Signal Transduction/drug effects , Thromboxane A2/biosynthesis , Thromboxane-A Synthase/drug effects , Thromboxane-A Synthase/metabolism
18.
Planta Med ; 73(2): 121-7, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17410649

ABSTRACT

Carnosic acid is a major phenolic diterpene derived from Rosmarinus officinalis and has been reported to have antioxidant, antibacterial, anticancer, antiobese and photoprotective activities. This study investigated the antiplatelet activity of carnosic acid. carnosic acid significantly inhibited collagen-, arachidonic acid-, U46619- and thrombin-induced washed rabbit platelet aggregation in a concentration-dependent manner, with IC50 values of 39+/-0.3, 34+/-1.8, 29+/-0.8 and 48+/-2.9 microM, respectively, while it failed to inhibit PMA-(a direct PKC activator) and ADP-induced platelet aggregation. In agreement with its antiplatelet activity, carnosic acid blocked collagen-, arachidonic acid-, U46619- and thrombin-mediated cytosolic calcium mobilization. accordingly, serotonin secretion and arachidonic acid liberation were also inhibited in a similar concentration-dependent manner. However, in contrast to the inhibition of arachidonic acid-induced platelet aggregation, carnosic acid had no effect on the formation of arachidonic acid-mediated thromboxane A2 and prostaglandin D2, thus indicating that carnosic acid has no effect on the cyclooxygenase and thromboxane A2 synthase activity. Overall, these results suggest that the antiplatelet activity of carnosic acid is mediated by the inhibition of cytosolic calcium mobilization and that carnosic acid has the potential of being developed as a novel antiplatelet agent.


Subject(s)
Abietanes/pharmacology , Plant Extracts/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation/drug effects , Rosmarinus/chemistry , Abietanes/chemistry , Abietanes/isolation & purification , Animals , Blood Platelets/drug effects , Blood Platelets/metabolism , Calcium/metabolism , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/isolation & purification , Rabbits , Rats
19.
Basic Clin Pharmacol Toxicol ; 100(3): 170-5, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17309520

ABSTRACT

The antithrombotic and antiplatelet activities of Korean red ginseng extract (KRGE) were examined on rat carotid artery thrombosis in vivo and platelet aggregation in vitro and ex vivo. The KRGE significantly prevented rat carotid arterial thrombosis in vivo in a dose-dependent manner. Administration of the KRGE to rats significantly inhibited adenosine diphosphate (ADP)- and collagen-induced platelet aggregation ex vivo, although it failed to prolong coagulation times such as activated partial thromboplastin and prothrombin time indicating that the antithrombotic effect of the red ginseng may be due to its antiplatelet aggregation rather than anticoagulation effect. In line with the above observations, the red ginseng inhibited the U46619-, arachidonic acid-, collagen- and thrombin-induced rabbit platelet aggregations in vitro in a concentration-dependent manner, with IC(50) values of 390 +/- 15, 485 +/- 19, 387 +/- 11 and 335 +/- 15 microg/ml, respectively. Consistently, serotonin secretion was also inhibited by ginseng in the same pattern. These results suggest that the red ginseng has a potent antithrombotic effect in vivo, which may be due to the antiplatelet rather than the anticoagulation activity, and the red ginseng intake may be beneficial for individuals with high risks of thrombotic and cardiovascular diseases.


Subject(s)
Carotid Artery Thrombosis/prevention & control , Fibrinolytic Agents/pharmacology , Panax , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation/drug effects , Animals , Blood Coagulation Tests , Dose-Response Relationship, Drug , Fibrinolytic Agents/administration & dosage , Fibrinolytic Agents/chemistry , In Vitro Techniques , Korea , Male , Partial Thromboplastin Time , Plant Extracts , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/chemistry , Prothrombin Time , Rabbits , Rats , Rats, Sprague-Dawley , Serotonin/metabolism , Thrombosis/prevention & control
20.
Atherosclerosis ; 194(1): 144-52, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17092506

ABSTRACT

Diet can be one of the most important factors that influence risks for atherothrombotic diseases. Hesperetin included in grapefruits and oranges is one candidate that may benefit the cardiovascular system. Here, we investigated antiplatelet activity of hesperetin in vitro. In addition, possible antiplatelet mechanism was also investigated. Hesperetin concentration-dependently inhibited washed rabbit platelet aggregation induced by collagen and arachidonic acid, with IC50 of 20.5+/-3.5 and 69.2+/-5.1 microM, respectively, while has little effect on thrombin- or U46619-, a thromboxane (TX) A2 mimic, mediated platelet aggregation, suggesting that hesperetin may selectively inhibit collagen- and arachidonic acid-mediated signal transduction. In accordance with these findings, hesperetin revealed blocking of the collagen-mediated phospholipase (PL) C-gamma2 phosphorylation, and caused concentration-dependent decreases of cytosolic calcium mobilization, arachidonic acid liberation and serotonin secretion. In addition, hesperetin inhibited arachidonic acid-mediated platelet aggregation by interfering with cyclooxygenase-1 activity as established by the measurement of arachidonic acid-mediated TXA2 and prostaglandin D2 formations as well as cyclooxygenase-1 and TXA2 synthase activity assays. Taken together, the present results provide a cellular mechanism for the antiplatelet activity of hesperetin through inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity, which may contribute to the beneficial effects of grapefruits and oranges on cardiovascular system.


Subject(s)
Blood Platelets/drug effects , Cyclooxygenase 1/metabolism , Hesperidin/pharmacology , Phospholipase C gamma/metabolism , Platelet Aggregation Inhibitors/pharmacology , Animals , Arachidonic Acid/metabolism , Blood Platelets/enzymology , Blood Platelets/metabolism , Calcium/metabolism , Collagen/pharmacology , Flavonoids/chemistry , Flavonoids/pharmacology , Hesperidin/chemistry , Phosphorylation , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/chemistry , Prostaglandin D2/metabolism , Rabbits , Serotonin/metabolism , Thromboxane-A Synthase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...